For Information
ELIXIR Director and interim Director updates
Niklas Blomberg will be moving on from his role as ELIXIRs Director at the end of this year to join the Innovative Health Initiative (IHI) as Executive Director. In October, the ELIXIR Board approved the recommendation from the Director Search Committee on a preferred candidate for the Director position. The name and starting date of the new Director will be confirmed in due course. For the interim period, the ELIXIR Board also approved that Andy Smith, Head of External Relations, will act as interim Director, starting on 1 December 2023.
Launch of Commissioned Services starting in January 2024
Following a successful ELIXIR Board meeting held on 30-31 October in Barcelona, Spain, eight Commissioned Services (CoS) have been approved for funding, starting in January 2024; three within the Science tier and five within the Technology tier.
There are several steps that need to be taken to prepare for the launch of the new ELIXIR 2024-2028 Programme and the start of eight Commissioned Services.
The Hub has started the process of confirming administrative and financial information essential to ensure the Proposal of Funding letters (PoFs) can be executed and the pre-financing can be processed. Nodes will receive e-mails with the detailed overview of their participation in approved CoS and will be asked to confirm / provide further administrative and financial information necessary for the process.
The provisional deadline is set to 24 November, however, if there are any issues with reaching it, please get in touch with Kelly Tunstall (kelly.tunstall@elixir-europe.org).
Key Dates and Meetings
7 December 2023 | 11:00-14:00 (CET)
1 February 2024 | 11:00-14:00 (CET)
15-16 May 2024 | Prague, Czech Republic